^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    OvaME

    Company:
    GenoME Diagnostics
    Type:
    Laboratory Developed Test
    Details
    Evidence

    News

    over1year
    Northern Ireland-based cancer Dx firm GenoMe Diagnostics raises £1.4M (Precision Oncology News)
    "GenoMe Diagnostics...said that it has raised £1.4 million ($1.7 million) in private and public funding to support the development of a blood test called OvaMe for early-stage detection of ovarian cancer...The new funding will support the development of OvaMe as well as regulatory filings in the EU, the UK, and North America."
    Financing
    |
    OvaME